Business · 1 sources covering this

Centre cuts MRPs for trade-margin-capped cancer meds by up to 93%

Major innovator brands see no price reductions despite cuts of up to 93 per cent for some cancer medicines; patient groups say PAP exclusions and data gaps have diluted relief

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·2h ago
Centre cuts MRPs for trade-margin-capped cancer meds by up to 93%
Major innovator brands see no price reductions despite cuts of up to 93 per cent for some cancer medicines; patient groups say PAP exclusions and data gaps have diluted relief
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/7cc6194737fc8933bac443c65808c62e621697d4"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Centre cuts MRPs for trade-margin-capped cancer meds by up to 93%"></iframe>

Centre cuts MRPs for trade-margin-capped cancer meds by up to 93%

How 1 sources are covering this

Centre cuts MRPs for trade-margin-capped cancer meds by up to 93%

More from Business

She spent ₹200 at Garba event in MP; a year later, her grandson won ₹50 lakh Fortuner his family had long dreamt of

Bengaluru man pays ₹12,500 monthly for 40 months, gets ₹20,000 from chit fund: Consumer court orders ₹4.08 lakh payout

L&T aims to nearly double order book to Rs 15 lakh crore by 2031

Hyundai Motor India Q2 profit falls 23.9% as raw material costs rise

Reader

Trust & legal

Across the network